Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/25 16:06 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Horn Margaret A | CA | O | COO | 1 | S | -140 | 39.83 | 0 | -4 | 151 | D | |||||||||||||||
6/18/25 16:06 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Goldsmith Mark A | CA | DO | See Rema | 1 | S | -538 | 39.83 | 0 | -13 | 935 | D | |||||||||||||||
6/18/25 16:06 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Cislini Jeff | CA | O | GC | 2 | S | -154 | 39.25 | 0 | -4 | 58 | D | |||||||||||||||
6/18/25 16:05 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Anders Jack | CA | O | CFO | 1 | S | -86 | 39.83 | 0 | -2 | 113 | D | |||||||||||||||
6/18/25 16:05 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Kelsey Stephen Michael | CA | O | See Rema | 1 | S | -171 | 39.83 | 0 | -4 | 289 | D | |||||||||||||||
6/18/25 16:05 | 6/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Wei Lin | CA | O | Chief Me | 1 | S | -87 | 39.83 | 0 | -2 | 90 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |